Literature DB >> 8436978

Labelling of 5-hydroxytryptamine3 receptors with a novel 5-HT3 receptor ligand, [3H]RS-42358-197.

E H Wong1, D W Bonhaus, I Wu, E Stefanich, R M Eglen.   

Abstract

RS-42358-197[(S)-N-(1-azabicyclo[2.2.2]oct-3-yl)-2,4,5,6-tetrahydro-1 H-benzo[de]isoquinolin-1-one hydrochloride] displaced the prototypic 5-hydroxytryptamine3 (5-HT3) receptor ligand [3H]quipazine in rat cerebral cortical membranes with an affinity (pKi) of 9.8 +/- 0.1, while having weak affinity (pKi < 6.0) in 23 other receptor binding assays. [3H]RS-42358-197 was then utilized to label 5-HT3 receptors in a variety of tissues. [3H]RS-42358-197 labelled high-affinity and saturable binding sites in membranes from rat cortex, NG108-15 cells, and rabbit ileal myenteric plexus with affinities (KD) of 0.12 +/- 0.01, 0.20 +/- 0.01, and 0.10 +/- 0.01 nM and densities (Bmax) of 16.0 +/- 2.0, 660 +/- 74, and 88 +/- 12 fmol/mg of protein, respectively. The density of sites labelled in each of these tissues with [3H]RS-42358-197 was similar to that labelled with [3H]GR 65630, but was significantly less than that found with [3H]-quipazine. The binding of [3H]RS-42358-197 had a pharmacological profile similar to that of [3H]quipazine, as indicated by the rank order of displacement potencies: RS-42358-197 > (S)-zacopride > tropisetron > (R)-zacopride > ondansetron > MDL72222 > 5-HT. However, differences in 5-HT3 receptors of different tissues and species were detected on the basis of statistically significant differences in the affinities of phenylbiguanide, and 1-(m-chlorophenyl)biguanide when displacing [3H]RS-42358-197 binding. [3H]RS-42358-197 also labelled a population (Bmax = 91 +/- 17 fmol/mg of protein) of binding sites in guinea pig myenteric plexus membranes, with lower affinity (KD = 1.6 +/- 0.3 nM) than those in the other preparations. Moreover, the rank order of displacement potencies of 15 5-HT3 receptor ligands in guinea pig ileum was found not to be identical to that in other tissues. Binding studies carried out with [3H]RS-42358-197 have detected differences in 5-HT3 receptor binding sites in tissues of different species and further underscore the unique nature of the guinea pig 5-HT3 receptor.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8436978     DOI: 10.1111/j.1471-4159.1993.tb03238.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  10 in total

1.  Poster communications.

Authors: 
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

2.  Characterization of a human 5-hydroxytryptamine3 receptor type A (h5-HT3R-AS) subunit stably expressed in HEK 293 cells.

Authors:  A G Hope; J A Peters; A M Brown; J J Lambert; T P Blackburn
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

3.  A pharmacological comparison of [3H]-granisetron binding sites in brain and peripheral tissues of the mouse.

Authors:  M J Perren; H Rogers; G S Mason; D R Bull; G J Kilpatrick
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-03       Impact factor: 3.000

4.  RS 23597-190: a potent and selective 5-HT4 receptor antagonist.

Authors:  R M Eglen; K Bley; D W Bonhaus; R D Clark; S S Hegde; L G Johnson; E Leung; E H Wong
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

5.  The pharmacology of VA21B7: an atypical 5-HT3 receptor antagonist with anxiolytic-like properties in animal models.

Authors:  I Artaiz; G Romero; A Zazpe; A Monge; J M Calderó; J Roca; B Lasheras; J Del Río
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

6.  Evidence that the atypical 5-HT3 receptor ligand, [3H]-BRL46470, labels additional 5-HT3 binding sites compared to [3H]-granisetron.

Authors:  L J Steward; J Ge; K R Bentley; P C Barber; A G Hope; J J Lambert; J A Peters; T P Blackburn; N M Barnes
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

7.  RS 39604: a potent, selective and orally active 5-HT4 receptor antagonist.

Authors:  S S Hegde; D W Bonhaus; L G Johnson; E Leung; R D Clark; R M Eglen
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

8.  The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.

Authors:  E H Wong; R Clark; E Leung; D Loury; D W Bonhaus; L Jakeman; H Parnes; R L Whiting; R M Eglen
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

9.  The interaction of antidepressant drugs with central and peripheral (enteric) 5-HT3 and 5-HT4 receptors.

Authors:  A Lucchelli; M G Santagostino-Barbone; A Barbieri; S M Candura; M Tonini
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

10.  Building a 5-HT3A Receptor Expression Map in the Mouse Brain.

Authors:  Yoshihisa Koyama; Makoto Kondo; Shoichi Shimada
Journal:  Sci Rep       Date:  2017-03-09       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.